Alaunos Therapeutics
TCRT
TCRT
128 hedge funds and large institutions have $237M invested in Alaunos Therapeutics in 2017 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 37 increasing their positions, 31 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% less ownership
Funds ownership: 0.27% → 0.27% (-0%)
33% less capital invested
Capital invested by funds: $356M → $237M (-$119M)
55% less call options, than puts
Call options by funds: $3.06M | Put options by funds: $6.77M
Holders
128
Holding in Top 10
3
Calls
$3.06M
Puts
$6.77M
Top Buyers
| 1 | +$5.74M | |
| 2 | +$1.26M | |
| 3 | +$1.16M | |
| 4 |
Citigroup
New York
|
+$1.12M |
| 5 |
MVP
Miller Value Partners
Sarasota,
Florida
|
+$935K |
Top Sellers
| 1 | -$14.6M | |
| 2 | -$727K | |
| 3 | -$437K | |
| 4 |
ARTA
A.R.T. Advisors
New York
|
-$406K |
| 5 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
-$376K |